Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting

Oncotarget
Brian DoughertyJ Carl Barrett

Abstract

To gain a better understanding of the role of somatic mutations in olaparib response, next-generation sequencing (NGS) of BRCA1 and BRCA2 was performed as part of a planned retrospective analysis of tumors from a randomized, double-blind, Phase II trial (Study 19; D0810C00019; NCT00753545) in 265 patients with platinum-sensitive high-grade serous ovarian cancer. BRCA1/2 loss-of-function mutations were found in 55% (114/209) of tumors, were mutually exclusive, and demonstrated high concordance with Sanger-sequenced germline mutations in matched blood samples, confirming the accuracy (97%) of tumor BRCA1/2 NGS testing. Additionally, NGS identified somatic mutations absent from germline testing in 10% (20/209) of the patients. Somatic mutations had >80% biallelic inactivation frequency and were predominantly clonal, suggesting that BRCA1/2 loss occurs early in the development of these cancers. Clinical outcomes between placebo- and olaparib-treated patients with somatic BRCA1/2 mutations were similar to those with germline BRCA1/2 mutations, indicating that patients with somatic BRCA1/2 mutations benefit from treatment with olaparib.

References

Oct 7, 1994·Science·P A FutrealY Miki
Apr 17, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·C Sue RichardsUNKNOWN Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bryan T J HennessyGordon B Mills
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Mar 29, 2012·The New England Journal of Medicine·Jonathan LedermannUrsula Matulonis
Aug 15, 2012·Journal of Medical Genetics·Amanda B SpurdleUNKNOWN ENIGMA Consortium
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Nov 19, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathryn P PenningtonElizabeth M Swisher
Apr 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W KurianJames M Ford
Apr 19, 2016·American Journal of Human Genetics·Brennan DeckerElaine A Ostrander
May 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C WinterL H Saal
Oct 9, 2016·The New England Journal of Medicine·Mansoor R MirzaUNKNOWN ENGOT-OV16/NOVA Investigators

❮ Previous
Next ❯

Citations

Feb 22, 2018·Cancer Chemotherapy and Pharmacology·Robert D MorganGordon C Jayson
Mar 6, 2018·The American Journal of Surgical Pathology·Deyin XingBrigitte M Ronnett
Jan 24, 2019·Journal of Cellular and Molecular Medicine·Xuan JiangZhenyu Zhang
May 22, 2019·Diagnostics·Stergios BoussiosNicholas Pavlidis
Jan 28, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Panagiotis A KonstantinopoulosChristina M Annunziata
Jun 15, 2017·Oncotarget·Angela GeorgeStan Kaye
May 6, 2020·Cancer Management and Research·Winston WongGulam A Manji
Apr 23, 2019·International Journal of Cancer. Journal International Du Cancer·Jonas LeichsenringAlbrecht Stenzinger
Feb 23, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Rebecca ArendRobert L Coleman
Mar 22, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sarah A Cook, Anna V Tinker
Sep 25, 2018·NPJ Precision Oncology·Soochi KimYong Sang Song
Jun 24, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Neelima VidulaAditya Bardia
Oct 6, 2020·Gynecologic Oncology·Elizabeth H StoverJoyce F Liu
Oct 10, 2020·Seminars in Diagnostic Pathology·Deyin Xing, Oluwole Fadare
Apr 4, 2021·International Journal of Environmental Research and Public Health·Mateusz KozłowskiAneta Cymbaluk-Płoska
Mar 21, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ailith EwingColin A Semple
Oct 3, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R E MillerL R Yates

❮ Previous
Next ❯

Datasets Mentioned

BETA
RCV000195350

Methods Mentioned

BETA
biopsies
Illumina sequencing

Clinical Trials Mentioned

NCT00753545

Software Mentioned

ClinVar

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Related Papers

The New England Journal of Medicine
Jonathan A LedermannUrsula A Matulonis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Stephanie LheureuxAmit M Oza
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Angeles Alvarez SecordLaura J Havrilesky
© 2022 Meta ULC. All rights reserved